Teza Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Teza Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $1.08 Million - $1.47 Million	-7,396 Reduced 64.75%	4,026 $601,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $1.53 Million - $1.99 Million	10,104 Added 766.62%	11,422 $2.19 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $225,074 - $278,954	1,318 New	1,318 $233,000
Q1 2023 Feb 22, 2024	SELL	$182.66 - $235.53 $1.77 Million - $2.28 Million	-9,687 Reduced 84.81%	1,735 $347,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $629,811 - $812,107	3,448 New	3,448 $690,000

Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $901,290 - $1.23 Million	-7,437 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$104.21 - $156.44 $566,172 - $849,938	5,433 Added 271.11%	7,437 $1.1 Million
Q1 2020 May 11, 2020	SELL	$93.12 - $133.99 $66,767 - $96,070	-717 Reduced 26.35%	2,004 $218,000
Q4 2019 Feb 12, 2020	BUY	$74.51 - $124.23 $202,741 - $338,029	2,721 New	2,721 $313,000

926

117M

1.25M

1.49M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $55.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.